243 related articles for article (PubMed ID: 17611778)
1. Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma.
Bai X; Wu L; Liang T; Liu Z; Li J; Li D; Xie H; Yin S; Yu J; Lin Q; Zheng S
J Cancer Res Clin Oncol; 2008 Jan; 134(1):83-91. PubMed ID: 17611778
[TBL] [Abstract][Full Text] [Related]
2. CaMK activation during exercise is required for histone hyperacetylation and MEF2A binding at the MEF2 site on the Glut4 gene.
Smith JA; Kohn TA; Chetty AK; Ojuka EO
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E698-704. PubMed ID: 18647882
[TBL] [Abstract][Full Text] [Related]
3. Caffeine induces hyperacetylation of histones at the MEF2 site on the Glut4 promoter and increases MEF2A binding to the site via a CaMK-dependent mechanism.
Mukwevho E; Kohn TA; Lang D; Nyatia E; Smith J; Ojuka EO
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E582-8. PubMed ID: 18198354
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.
Maiti D; Xu Z; Duh EJ
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3640-8. PubMed ID: 18450586
[TBL] [Abstract][Full Text] [Related]
5. Alpha-actinin 4 potentiates myocyte enhancer factor-2 transcription activity by antagonizing histone deacetylase 7.
Chakraborty S; Reineke EL; Lam M; Li X; Liu Y; Gao C; Khurana S; Kao HY
J Biol Chem; 2006 Nov; 281(46):35070-80. PubMed ID: 16980305
[TBL] [Abstract][Full Text] [Related]
6. Dual roles for MEF2A and MEF2D during human macrophage terminal differentiation and c-Jun expression.
Aude-Garcia C; Collin-Faure V; Bausinger H; Hanau D; Rabilloud T; Lemercier C
Biochem J; 2010 Sep; 430(2):237-44. PubMed ID: 20590529
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2.
Han A; He J; Wu Y; Liu JO; Chen L
J Mol Biol; 2005 Jan; 345(1):91-102. PubMed ID: 15567413
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility.
Wang YX; Qian LX; Liu D; Yao LL; Jiang Q; Yu Z; Gui YH; Zhong TP; Song HY
Cardiovasc Res; 2007 May; 74(2):290-303. PubMed ID: 17367767
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional induction of MMP-10 by TGF-beta, mediated by activation of MEF2A and downregulation of class IIa HDACs.
Ishikawa F; Miyoshi H; Nose K; Shibanuma M
Oncogene; 2010 Feb; 29(6):909-19. PubMed ID: 19935709
[TBL] [Abstract][Full Text] [Related]
11. Regulatory polymorphism in transcription factor KLF5 at the MEF2 element alters the response to angiotensin II and is associated with human hypertension.
Oishi Y; Manabe I; Imai Y; Hara K; Horikoshi M; Fujiu K; Tanaka T; Aizawa T; Kadowaki T; Nagai R
FASEB J; 2010 Jun; 24(6):1780-8. PubMed ID: 20086047
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression.
Méjat A; Ramond F; Bassel-Duby R; Khochbin S; Olson EN; Schaeffer L
Nat Neurosci; 2005 Mar; 8(3):313-21. PubMed ID: 15711539
[TBL] [Abstract][Full Text] [Related]
13. GADD45-alpha expression in cirrhosis and hepatocellular carcinoma: relationship with DNA repair and proliferation.
Gramantieri L; Chieco P; Giovannini C; Lacchini M; Treré D; Grazi GL; Venturi A; Bolondi L
Hum Pathol; 2005 Nov; 36(11):1154-62. PubMed ID: 16260267
[TBL] [Abstract][Full Text] [Related]
14. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
Tátrai P
Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
[TBL] [Abstract][Full Text] [Related]
15. Salvianolic Acid B Inhibits Activation of Human Primary Hepatic Stellate Cells Through Downregulation of the Myocyte Enhancer Factor 2 Signaling Pathway.
Zhang W; Ping J; Zhou Y; Chen G; Xu L
Front Pharmacol; 2019; 10():322. PubMed ID: 31031620
[TBL] [Abstract][Full Text] [Related]
16. The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma.
Yuan JH; Yang F; Chen BF; Lu Z; Huo XS; Zhou WP; Wang F; Sun SH
Hepatology; 2011 Dec; 54(6):2025-35. PubMed ID: 21837748
[TBL] [Abstract][Full Text] [Related]
17. HDAC4 deacetylase associates with and represses the MEF2 transcription factor.
Miska EA; Karlsson C; Langley E; Nielsen SJ; Pines J; Kouzarides T
EMBO J; 1999 Sep; 18(18):5099-107. PubMed ID: 10487761
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
Clin Cancer Res; 2002 Oct; 8(10):3131-6. PubMed ID: 12374680
[TBL] [Abstract][Full Text] [Related]
19. Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders.
Bachinski LL; Sirito M; Böhme M; Baggerly KA; Udd B; Krahe R
Muscle Nerve; 2010 Dec; 42(6):856-63. PubMed ID: 21104860
[TBL] [Abstract][Full Text] [Related]
20. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
Buurman R; Sandbothe M; Schlegelberger B; Skawran B
Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
